explore -WSS

explore

author：explore 2025-10-02 21:36:05 - browse：32895

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Novo Nordisk testing Wegovy against alcohol

WSS

Supreme Court to hear if Covid misinformation is protected speech

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Supreme Court to hear if Covid misinformation is protected speech

ALS treatment from Biogen, Ionis fails in study

CVS is willing to dump 10% of its Medicare Advantage members

Wikipedia

explore

Gilead needs Arcellx more than ever

focus

Cancer drug shortages should be causing more outrage

Hottest summer in 2,000 years puts focus on extreme heat, health

Sports medicine is finally prioritizing gender equality

Physicians aren't 'burning out.' They're suffering from moral injury

Malaria cases in Florida and Texas: Here’s what you need to know

HHS suspends federal funding for EcoHealth Alliance

Malaria cases in Florida and Texas: Here’s what you need to know

Chris Christie meets with Zelenskyy during Ukraine trip

Sports medicine is finally prioritizing gender equality

Abbott's new stent may help patients with peripheral artery disease

hotspot

STAT series 'Denied by AI' wins major journalism prizes

Ripples from Flovent's discontinuation is killing children with asthma

'Null' research findings aren't empty of meaning. Let's publish them

Group behind ProMed defends move to subscription

The a glaring gap in research on serious mental illness and primary care

Supreme Court to hear if Covid misinformation is protected speech

hotspot

Wikipedia

focus

explore